This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with great interest the article by Njoo et al,¹ which gives valuable insight into the development, implementation, and evaluation of guidelines for the treatment of vitiligo by local physicians as well as experts. However, some important aspects of vitiligo in childhood should be considered. Because the course of this pigmentary disorder is variable, there is no evidence that early treatment of minimal disease alters the natural history.² Since vitiligo is not a life-threatening cutaneous condition, many children with little skin involvement in cosmetically unimportant areas do not wish to treat their disease.^2-3This should be considered when treating children and establishing guidelines.

Topical corticosteroids are useful in the treatment of young patients with only a few depigmented patches. In older children, the initial use of superpotent topical corticosteroids is accepted in areas other than the face and intertriginous regions.² For these regions, low-potency corticosteroids are more desirable.³ It . . . [Full Text of this Article]